Indo-Bangla Pharmaceuticals (DHA:IBP) Total Inventories: BDT0.00 Mil (As of . 20)

What is Indo-Bangla Pharmaceuticals Total Inventories?

Indo-Bangla Pharmaceuticals DHA:IBP +1.32% 32 Total Inventories is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Indo-Bangla Pharmaceuticals's total inventories for the quarter that ended in . 20 was BDT0.00 Mil. Indo-Bangla Pharmaceuticals's average total inventories from the quarter that ended in . 20 to the quarter that ended in . 20 was BDT0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Indo-Bangla Pharmaceuticals's Net-Net Working Capital per share for the quarter that ended in . 20 was BDTN/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Indo-Bangla Pharmaceuticals (DHA:IBP) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Indo-Bangla Pharmaceuticals's Net-Net Working Capital Per Share for the quarter that ended in . 20 is

	Net-Net Working Capital Per Share (Q: . 20 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(	+	0.75 *	+	0.5 *	-	N/A
-		-	)	/	0
=	N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Indo-Bangla Pharmaceuticals's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory	=	Average Total Inventories (Q: . 20 )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
	=	0	/		*	365 / 2
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Indo-Bangla Pharmaceuticals's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: . 20 )	/	Average Total Inventories (Q: . 20 )
	=		/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Indo-Bangla Pharmaceuticals's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: . 20 )	/	Revenue (Q: . 20 )
	=	0	/
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Indo-Bangla Pharmaceuticals Total Inventories Related Terms

Indo-Bangla Pharmaceuticals Total Inventories Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Total Inventories can be seen below:

Indo-Bangla Pharmaceuticals Total Inventories Chart

Indo-Bangla Pharmaceuticals Annual Data

Trend

Total Inventories

Indo-Bangla Pharmaceuticals Semi-Annual Data

Total Inventories

32GF Score

Indo-Bangla Pharmaceuticals Ltd DHA:IBP

Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Indo-Bangla Pharmaceuticals Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →

What does a Total Inventories of BDT0.00 Mil mean?

Indo-Bangla Pharmaceuticals (DHA:IBP) has a Total Inventories of BDT0.00 Mil as of . 20. The total amount of inventory as recorded on a company's balance sheet. View historical data for Indo-Bangla Pharmaceuticals and its competitors.

Is Indo-Bangla Pharmaceuticals' Total Inventories too high?

Indo-Bangla Pharmaceuticals' current Total Inventories is BDT0.00 Mil. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.

How does Indo-Bangla Pharmaceuticals' Total Inventories compare to ?

Indo-Bangla Pharmaceuticals' Total Inventories of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Inventories for a Drug Manufacturers company?

A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Inventories mean?

A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Total Inventories is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Indo-Bangla Pharmaceuticals stock overvalued right now?

Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Total Inventories of BDT0.00 Mil. The current Total Inventories is BDT0.00 Mil. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Inventories calculated?

Total Inventories is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Total Inventories is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies

Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229

Website https://www.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.

32GF Score

Get the complete analysis for DHA:IBP

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.30

Price

View DHA:IBP Analysis

See Total Inventories data for all stocks →